We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.48%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$34.5B
AUM Growth
+$1.76B
(+5.4%)
Cap. Flow
-$769M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.77%
Holding
1,963
New
176
Increased
1,051
Reduced
620
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$68.7M |
| 2 |
GE HealthCare
GEHC
|
+$28.6M |
| 3 |
ON Semiconductor
ON
|
+$28.1M |
| 4 |
Caterpillar
CAT
|
+$22.6M |
| 5 |
IBM
IBM
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$94.9M |
| 2 |
Apple
AAPL
|
+$91M |
| 3 |
West Pharmaceutical
WST
|
+$69M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$61.8M |
| 5 |
Amazon
AMZN
|
+$55.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Industrials | 12.05% |
| 3 | Consumer Staples | 10.74% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
B&G Foods
BGS
$285M
| $155K | ﹤0.01% |
11,137
+854
| +8% | +$12.3K |
|
1602
ADMA Biologics
ADMA
$1.92B
| $154K | ﹤0.01% |
41,778
+1,821
| +5% | +$6.75K |
|
1603
Hope Bancorp
HOPE
$1.72B
| $153K | ﹤0.01% |
18,152
+1,249
| +7% | +$10.9K |
|
|
RNAM
1604
DELISTED
Avidity Biosciences
RNAM
| $153K | ﹤0.01% |
13,777
+1,184
| +9% | +$14.9K |
|
1605
Cytek Biosciences
CTKB
$576M
| $152K | ﹤0.01% |
17,853
+4,414
| +33% | +$39.6K |
|
|
PACW
1606
DELISTED
PacWest Bancorp
PACW
| $152K | ﹤0.01% |
+18,687
| New | +$151K |
|
1607
DHT Holdings
DHT
$2.97B
| $152K | ﹤0.01% |
17,849
+1,728
| +11% | +$15.1K |
|
1608
Novavax
NVAX
$1.23B
| $152K | ﹤0.01% |
+20,451
| New | +$161K |
|
|
VISN
1609
Vistance Networks Inc
VISN
$2.66B
| $152K | ﹤0.01% |
26,968
+2,824
| +12% | +$13.5K |
|
1610
Summit Therapeutics
SMMT
$10.6B
| $151K | ﹤0.01% |
60,214
+11,844
| +24% | +$21.6K |
|
1611
Upwork
UPWK
$1.09B
| $150K | ﹤0.01% |
16,102
+1,805
| +13% | +$16.4K |
|
|
MFA
1612
MFA Financial
MFA
$929M
| $150K | ﹤0.01% |
13,313
+1,232
| +10% | +$13.1K |
|
1613
Hims & Hers Health
HIMS
$6.5B
| $149K | ﹤0.01% |
15,899
+1,614
| +11% | +$16K |
|
1614
Zeta Global
ZETA
$4.77B
| $149K | ﹤0.01% |
17,463
+4,388
| +34% | +$40.1K |
|
1615
Arlo Technologies
ARLO
$1.4B
| $149K | ﹤0.01% |
13,639
+1,005
| +8% | +$8.17K |
|
|
DCH
1616
Dauch Corp
DCH
$1.3B
| $148K | ﹤0.01% |
17,912
+1,482
| +9% | +$11K |
|
1617
Sana Biotechnology
SANA
$885M
| $146K | ﹤0.01% |
24,519
+820
| +3% | +$4.73K |
|
|
ETWO
1618
DELISTED
E2open Parent Holdings
ETWO
| $145K | ﹤0.01% |
25,955
+2,505
| +11% | +$13.5K |
|
|
FSR
1619
DELISTED
Fisker Inc.
FSR
| $144K | ﹤0.01% |
25,521
+4,680
| +22% | +$27K |
|
1620
WisdomTree
WT
$2.97B
| $144K | ﹤0.01% |
20,921
+1,849
| +10% | +$12.4K |
|
|
SLCA
1621
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $143K | ﹤0.01% |
11,821
+1,032
| +10% | +$12.8K |
|
1622
AvePoint
AVPT
$2.6B
| $142K | ﹤0.01% |
24,720
+6,813
| +38% | +$35.9K |
|
1623
Ecovyst
ECVT
$1.36B
| $142K | ﹤0.01% |
+12,389
| New | +$135K |
|
|
ADAM
1624
Adamas Trust
ADAM
$777M
| $141K | ﹤0.01% |
14,224
+805
| +6% | +$7.99K |
|
1625
Aclaris Therapeutics
ACRS
$730M
| $141K | ﹤0.01% |
13,606
+1,378
| +11% | +$12.5K |
|
Similar funds
ProShare Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, ProShare Advisors held 1,963 positions worth $34.5B, up 5.4% from $32.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
ProShare Advisors's Q2 2023 filing shows 176 new, 1,051 increased, 620 reduced and 112 closed positions. Its largest new stake was Artesian Resources: 162,581 shares worth $7.68M. The largest sale was Microsoft, an estimated $94.9M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q2 2023 buy was Artesian Resources: 162,581 shares worth $7.68M.
- ProShare Advisors added most to Albemarle in Q2 2023, an estimated $68.7M increase.
- ProShare Advisors's biggest Q2 2023 reduction was Microsoft, cutting an estimated $94.9M.
- ProShare Advisors fully exited Rivian in Q2 2023, selling an estimated $11.9M.
- ProShare Advisors's ten largest holdings make up 27% of its $34.5B portfolio in Q2 2023.
- ProShare Advisors opened 176 new positions and closed 112 in Q2 2023.
- ProShare Advisors's portfolio value rose 5.4% quarter-over-quarter to $34.5B.
Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.